Sjögren’s Syndrome Clinical Trials

Sjogrens Syndrome Clinical Study

Compensation

Up to $2400

For Completed Study

Sjögren’s Syndrome Clinical research study

Diagnosed With Sjögren’s Syndrome?

Do you have Sjögren’s Syndrome and want to help drive medical research forward? Join our clinical trial to explore new treatment options while receiving compensation for your time and participation.

Find out if you qualify, learn about the trial process, and see how you can contribute to the future of Sjögren’s Syndrome treatments. Sign up below to get started!

are you interested in our clinical trial?

Sjögren’s Syndrome Study Eligibility

You could be eligible to participate in one of these research studies if you meet the following criteria:

Sjögren’s Syndrome Trial Eligibility Criteria

  • Adults age 18 to 75

  • Diagnosed with primary Sjögren’s Syndrome

  • Active Sjogren’s symptoms, including but not limited to fatigue, dry eyes, and dry mouth 

two convenient Tampa Bay locations

Study Locations

clearwater clinical research facility

Clearwater Facility

Enroll Now

2147 NE Coachman Road
Clearwater, FL 33765
727-466-0078
Clearwater location details

Tampa clinical research facility

Tampa Facility

Enroll Now

605 N. Howard Ave.
Tampa, FL 33606
813-870-1292
Tampa location details

Protocol: RC18G007 | Indication: Sjögren’s Syndrome

What To Know About Volunteering For Our Sjögren’s Syndrome Clinical Trial

Joining a clinical trial is entirely voluntary, and you have the freedom to withdraw at any time. The process begins by finding a suitable trial, consulting with study doctors to determine eligibility, signing an informed consent form, completing necessary screening tests, and enrolling if you meet the requirements.

Sjogren Clinical Research

Step 1:

Determine Eligibility

Complete our online form to check your eligibility for the Sjögren’s Syndrome Clinical Trial.

Clinical Study with Compensation

Step 2:

Participate In The Study

This Sjögren’s Syndrome study has approximately 16 office visits over 14 months.

Paid Sjogrens Study

Step 3:

Compensation For Time/Travel

If qualified, all study-related care is provided at no cost. Compensation may be provided for time and travel.

Why Participate in a Clinical Trial?

For individuals diagnosed with Sjögren’s Syndrome, participating in a clinical trial could provide an opportunity to explore new treatment options aimed at managing and alleviating symptoms.

  • No insurance required for this treatment

  • Study-related exams at no cost

  • The opportunity to try new treatments that could be more effective than conventional options

  • Contribute to future medical advances for Sjogren’s Syndrome

Sjogrens Syndrome Clinical Trial

Official Registered Study

These clinical trials are officially registered with the U.S. National Library of Medicine. You can view full study details, including eligibility and locations, at ClinicalTrials.gov under study numbers NCT06747949, NCT06979531, NCT06684847, NCT07404865 and NCT06544642.

want to learn more?

What is Sjögren’s Syndrome?

Sjögren’s Syndrome is a chronic autoimmune disorder in which the body’s immune system mistakenly attacks its own moisture-producing glands. This leads to a reduction in saliva and tear production, causing dryness in the mouth, eyes, and other parts of the body. Though it primarily affects the glands, it can also impact organs such as the kidneys, liver, and lungs.

The symptoms of Sjögren’s Syndrome can vary greatly from person to person but often include:

  • Dry mouth and difficulty swallowing
  • Dry, gritty feeling in the eyes
  • Joint pain and swelling
  • Fatigue and general malaise
  • Swollen glands, particularly in the neck and underarms
  • Vaginal dryness
  • Skin rashes or other skin issues

While there is no cure for Sjögren’s Syndrome, several treatments can help manage symptoms, including medications to increase moisture production and anti-inflammatory drugs to reduce joint pain and other symptoms. Early diagnosis and management can significantly improve quality of life for individuals affected by this condition.

More Detailed Information

Sjögren’s Syndrome Research Explained

At Clinical Research of West Florida, Sjögren’s Syndrome clinical trials are designed to explore new therapies and treatment options for this autoimmune disease. These trials play a crucial role in understanding the underlying mechanisms of the syndrome and developing effective treatments. Participants in these studies may be given either the experimental medication or a placebo in a controlled, randomized double-blind study, where neither the participant nor the researcher knows which treatment is being administered, ensuring unbiased and reliable results.

Individuals who join Sjögren’s Syndrome clinical trials can expect comprehensive care and regular health assessments, including tests to monitor eye moisture, saliva production, and overall organ function. Throughout the study, participants will receive close attention from a team of specialists who will guide them through their treatment and help manage any potential side effects. This supportive environment not only aids research but also provides valuable insights into managing the symptoms of Sjögren’s Syndrome.

The current clinical trials for Sjögren’s Syndrome are testing innovative therapies aimed at reducing inflammation and improving moisture production. These treatments may include biologics, which are medications designed to target specific immune system pathways, as well as other agents to improve gland function and alleviate discomfort. By participating in these trials, individuals gain access to the latest advancements in treating Sjögren’s Syndrome.

Understanding Placebo-Controlled Studies in Sjögren’s Syndrome Research

Placebo-controlled studies are an important part of Sjögren’s Syndrome clinical trials. In these studies, one group of participants receives the experimental treatment, while another group receives a placebo (an inactive substance). This method allows researchers to evaluate the true effectiveness of a treatment and ensures that any observed improvements are due to the therapy itself. Understanding the role of the placebo can help participants feel confident in their contribution to critical scientific research.

Evaluating the Effectiveness of New Sjögren’s Syndrome Therapies

The evaluation of new therapies in Sjögren’s Syndrome clinical trials involves assessing the effectiveness of the treatment in managing symptoms such as dry mouth, eye dryness, and joint pain. Researchers also evaluate how well these treatments may help prevent damage to other organs. This data is essential for determining whether a new therapy could be approved for use in the broader population and become part of standard treatment protocols.

Access to Advanced Treatment Options

One of the main benefits of joining a Sjögren’s Syndrome clinical trial is access to cutting-edge treatments that are still being developed. Participants may have the opportunity to try new therapies that could help reduce symptoms like dryness and inflammation, offering a potential improvement in their quality of life.

Contributing to Progress in Sjögren’s Syndrome Research

By participating in clinical trials, individuals help drive forward important research that can lead to better treatments and a deeper understanding of Sjögren’s Syndrome. This contribution could potentially benefit others living with the condition in the future.

Receiving Specialized Care and Support

Participants in clinical trials for Sjögren’s Syndrome receive regular evaluations from experts in autoimmune diseases. This high level of care includes monitoring for side effects, adjusting treatments as needed, and offering personalized support, which helps participants better manage their condition during the trial.

The Importance of Double-Blind Randomized Studies

The use of a double-blind randomized study design is crucial in Sjögren’s Syndrome trials. This means that participants are randomly assigned to receive either the study treatment or a placebo, with neither the participant nor the research team knowing who receives which treatment. This helps eliminate bias and ensures that the trial results are as reliable as possible.

Prioritizing Participant Safety and Monitoring

Safety is the foremost concern in clinical trials for Sjögren’s Syndrome. Participants are closely monitored for any adverse effects, and regular check-ins with the research team ensure that any issues are addressed promptly. This focus on safety and well-being helps participants feel confident and supported throughout the trial.

Maintaining High Standards of Care

Even while testing new treatments, clinical trials for Sjögren’s Syndrome adhere to the best practices for patient care. Participants continue to receive appropriate treatments for their condition, even if they are enrolled in a trial, ensuring that they receive optimal care alongside their participation in the study.

sjögren’s study questions

Sjögren’s Syndrome Clinical Trial FAQs

Quick answers to the questions volunteers ask most often about taking part in this study at CRWF, from who qualifies to what to expect at each visit.

Still have a question? Call us and a member of our team will be glad to help.

Sjögren’s Syndrome is a chronic autoimmune disease in which the immune system mistakenly attacks the body’s moisture-producing glands, reducing saliva and tear production. This causes dryness in the mouth, eyes, and other parts of the body, though it can also affect organs like the kidneys, liver, and lungs. Common symptoms include dry mouth and difficulty swallowing, a dry or gritty feeling in the eyes, joint pain and swelling, fatigue, swollen glands in the neck and underarms, vaginal dryness, and skin rashes. While there is no cure, treatments can help manage symptoms and improve quality of life.

To be eligible for the Sjögren’s Syndrome clinical trial at Clinical Research of West Florida, participants must be adults age 18 to 75 who have been diagnosed with primary Sjögren’s Syndrome and have active Sjögren’s symptoms, including but not limited to fatigue, dry eyes, and dry mouth. Final eligibility is confirmed through a screening visit with the study team at the Clearwater or Tampa facility.

Participants in the CRWF Sjögren’s Syndrome clinical trial may receive up to $2,400 in compensation for time and travel for completed study participation. Study-related care is provided at no cost and no health insurance is required to participate.

The CRWF Sjögren’s Syndrome clinical trial involves approximately 16 office visits over about 14 months, at either the Clearwater or Tampa facility. Participation is entirely voluntary and participants may withdraw at any time. Participants continue to receive appropriate standard-of-care treatment for their Sjögren’s Syndrome throughout the study.

Current Sjögren’s Syndrome clinical trials are investigating biologic therapies that target specific immune pathways, agents designed to improve moisture gland function, and treatments aimed at reducing inflammation throughout the body. The goal is to find out whether these investigational treatments may relieve symptoms like dry mouth, dry eyes, joint pain, and fatigue for people whose Sjögren’s is not fully controlled by existing treatments.

Yes. The current CRWF Sjögren’s Syndrome study is sponsor protocol RC18G007, registered on ClinicalTrials.gov as NCT07404865. CRWF Sjögren’s Syndrome research is also registered with the U.S. National Library of Medicine under study numbers NCT06747949, NCT06979531, NCT06684847, and NCT06544642. Participants can view full study details, eligibility, and locations on the ClinicalTrials.gov website.

To enroll in the Sjögren’s Syndrome clinical trial, call Clinical Research of West Florida in Clearwater at 727-466-0078 or in Tampa at 813-870-1292, or complete the online eligibility form on this page. The study team will review your medical history, confirm eligibility based on your diagnosis and current symptoms, and schedule a screening visit at the Clearwater facility (2147 NE Coachman Road) or the Tampa facility (605 N. Howard Ave.).

Interested In Learning More

Enroll Now